Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications

J Basic Microbiol. 2022 Sep;62(9):999-1029. doi: 10.1002/jobm.202100477. Epub 2022 Jan 11.

Abstract

Microalgae and cyanobacteria (blue-green algae) are used as food by humans. They have gained a lot of attention in recent years because of their potential applications in biotechnology. Microalgae and cyanobacteria are good sources of many valuable compounds, including important biologically active compounds with antiviral, antibacterial, antifungal, and anticancer activities. Under optimal growth condition and stress factors, algal biomass produce varieties of potential bioactive compounds. In the current review, bioactive compounds production and their remarkable applications such as pharmaceutical and nutraceutical applications along with processes involved in identification and characterization of the novel bioactive compounds are discussed. Comprehensive knowledge about the exploration, extraction, screening, and trading of bioactive products from microalgae and cyanobacteria and their pharmaceutical and other applications will open up new avenues for drug discovery and bioprospecting.

Keywords: algae; antibacterial; bioactive; bioprospecting; cyanobacteria.

Publication types

  • Review

MeSH terms

  • Biotechnology
  • Cyanobacteria*
  • Dietary Supplements
  • Humans
  • Microalgae*
  • Pharmaceutical Preparations

Substances

  • Pharmaceutical Preparations